Parth Desai

Partner

Parth is a Partner at Flare Capital Partners. Parth has a background in healthcare policy, operating, innovation and investing.

At Flare Capital he is a lead/co-lead investor and Board Member at SmarterDx, Board Member at Daffodil Health, Board Observer at Layer Health, Board Observer at Photon Health, Board Observer at Positive Development and investor in Flare Scholar Ventures investments Birch AI (acquired by Sagility), Jaide Health, Rosarium Health and Helm Health. Parth also supports or has co-led Flare Capital’s investments into Aetion, HealthVerity and Suki AI. He previously supported Bright Health (IPO) and HealthReveal (acquired by Accolade). Additionally, Parth is a member of Boston University School of Public Health’s Advisory Committee and Alumni Leadership Council.

Prior to joining Flare Capital, Parth was an investor at NewYork-Presbyterian Hospital (NYP) Ventures, where he focused on applications of artificial intelligence to healthcare operations, leading investments into Saykara (acquired by Nuance), Syllable AI and Workfusion. In addition to venture investing, he also worked with the hospital’s executive leadership team to commercialize internal innovation and structure strategic partnerships to enhance the hospital’s patient and clinician care experience.

Prior to joining NYP Ventures, Parth was a health care strategy consultant at Deloitte Consulting, responsible for developing corporate growth strategies, advising M&A transactions and supporting operational transformations for leading providers, payers and technology companies. Parth began his career as health policy analyst for the Massachusetts House of Representatives, where he primarily worked with the Patrick administration to manage reform of the pharmaceutical compounding industry, authoring legislation signed into law by Governor Deval Patrick and used by the FDA to model national regulations.

Parth earned his BS in Biology from Boston College, MPH in Health Policy and Management from Boston University School of Public Health and Masters in Medicine from Boston University School of Medicine.

Parth Desai
I am eager to partner with ambitious founders who bring visionary technology, relentless curiosity, and a shared humility to tackling healthcare’s deepest structural inefficiencies.
Socials
Parth’s Investments
Name Description Category Stage Invested Status Backed Since
AETION Aetion delivers real-world evidence for manufacturers, purchasers, and regulators of medical treatments. Infrastructure Series A Acquired 2017 BEAMING HEALTH Beaming Health connects families with therapists across home, clinic, and virtual care settings. Clinical Tech Pre-Seed Private 2021 BEME HEALTH BeMe improves mental health and emotional well-being for today’s teens. Tech-Enabled Services Seed Acquired 2021 BIRCHAI BirchAI automates contact center workflows with real-time generative AI. Infrastructure Seed Acquired 2022 DAFFODIL HEALTH Daffodil Health modernizes claims and pricing infrastructure for health plans with AI. Payer Tech Series A Private 2025 HEALTHVERITY HealthVerity powers a leading real-world healthcare and consumer data ecosystem. Infrastructure Series A Private 2016 HELM Helm builds health insurance plans with simple, upfront pricing. Payer Tech Seed Private 2026 JAIDE HEALTH Jaide Health delivers real-time, HIPAA-compliant AI translation for healthcare providers. Clinical Tech Pre-Seed Private 2026 LAYER HEALTH Layer Health uses AI to unify clinical data and support chart review workflows. Infrastructure Series A Private 2024 PHOTON HEALTH Photon enables patients to compare pharmacies on price, convenience, and availability. Pharma Tech Seed I Private 2024 POSITIVE DEVELOPMENT Positive Development supports neurodivergent youth in building skills to thrive and succeed. Tech-Enabled Services Series B Private 2022 ROSARIUM HEALTH Rosarium Health enables home modifications that support health outcomes and aging in place. Tech-Enabled Services Pre-Seed Private 2023 SMARTERDX SmarterDx uses AI to analyze patient records and support accurate capture of care value. Clinical Tech Seed Acquired 2022 SUKI Suki provides ambient clinical intelligence for documentation, revenue cycle, and clinical workflows. Clinical Tech Series B Private 2020